Literature DB >> 15196012

Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes.

Sébastien Deshayes1, Thomas Plénat, Gudrun Aldrian-Herrada, Gilles Divita, Christian Le Grimellec, Frédéric Heitz.   

Abstract

To identify rules for the design of efficient cell-penetrating peptides that deliver therapeutic agents into subcellular compartments, we compared the properties of two closely related primary amphipathic peptides that mainly differ by their conformational state. On the basis of a peptide Pbeta that is nonstructured in water and that promotes efficient cellular uptake of nucleic acids through noncovalent association, we have designed a peptide [Palpha] that is predicted to adopt a helical conformation. We show that [Pbeta] undergoes a lipid-induced conformational transition into a sheet structure, while [Palpha] remains helical. Penetration experiments show that both peptides can spontaneously insert into phospholipid membranes. Analysis of compression isotherms indicates that both peptides interact with phospholipids in the liquid expanded and liquid condensed states. AFM observations reveal that the peptides strongly disrupt the lipid organization of the monolayers and that the conformational state can influence the uptake by model membranes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196012     DOI: 10.1021/bi049298m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

Review 1.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

2.  Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures.

Authors:  Christina Foerg; Kathrin M Weller; Helene Rechsteiner; Hanne M Nielsen; Jimena Fernández-Carneado; René Brunisholz; Ernest Giralt; Hans P Merkle
Journal:  AAPS J       Date:  2008-06-28       Impact factor: 4.009

3.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.

Authors:  Zhengrong Guo; Huanyan Peng; Jiwen Kang; Dianxing Sun
Journal:  Biomed Rep       Date:  2016-03-23

Review 4.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

5.  Coexistence of a two-states organization for a cell-penetrating peptide in lipid bilayer.

Authors:  Thomas Plénat; Sylvie Boichot; Patrice Dosset; Pierre-Emmanuel Milhiet; Christian Le Grimellec
Journal:  Biophys J       Date:  2005-09-30       Impact factor: 4.033

Review 6.  Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Authors:  Chiranjeevi Peetla; Andrew Stine; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

7.  Secondary structure of cell-penetrating peptides during interaction with fungal cells.

Authors:  Zifan Gong; Svetlana P Ikonomova; Amy J Karlsson
Journal:  Protein Sci       Date:  2018-01-10       Impact factor: 6.725

8.  Chlorogenic Acid Improves Neuroprotective Effect of PEP-1-Ribosomal Protein S3 Against Ischemic Insult.

Authors:  Eun Hee Ahn; Dae Won Kim; Min Jea Shin; Soon Won Kwon; Young Nam Kim; Duk-Soo Kim; Soon Sung Lim; Joon Kim; Jinseu Park; Won Sik Eum; Hyun Sook Hwang; Soo Young Choi
Journal:  Exp Neurobiol       Date:  2011-12-29       Impact factor: 3.261

9.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.